Sarepta Therapeutics (SRPT) Net Cash Flow Growth (1y) (2011 - 2026)
Sarepta Therapeutics (SRPT) Net Cash Flow Growth (1y) (2011 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
NCF Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
198.34% |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
467.41% |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
- |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
-14,223.53% |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
453.08% |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
- |
| 10 |
Sarepta Therapeutics |
1.84 Bn |
1.16 Bn |
291.52 Mn |
60.93% |
| Date | Value |
|---|
| Mar 31, 2026 |
60.93% |
| Dec 31, 2025 |
-79.21% |
| Sep 30, 2025 |
153.84% |
| Jun 30, 2025 |
717.69% |
| Mar 31, 2025 |
-75,526.58% |
| Dec 31, 2024 |
873.16% |
| Sep 30, 2024 |
40.05% |
| Jun 30, 2024 |
-121.23% |
| Mar 31, 2024 |
98.80% |
| Dec 31, 2023 |
-62.95% |
| Sep 30, 2023 |
-281.65% |
| Jun 30, 2023 |
94.46% |
| Mar 31, 2023 |
89.22% |
| Dec 31, 2022 |
-113.89% |
| Sep 30, 2022 |
273.78% |
| Jun 30, 2022 |
-265.46% |
| Mar 31, 2022 |
-4,137.90% |
| Dec 31, 2021 |
1,714.55% |
| Sep 30, 2021 |
40.62% |
| Jun 30, 2021 |
273.39% |
